Abstract: The invention concerns anti-clusterin oligoclonal antibodies able to recognize and bind in a selective and specific way antigenic epitopes of clusterin isoforms to be used in tumors diagnosis and in the prediction of their malignancy grade, diagnostic method and related kits.
Type:
Grant
Filed:
February 17, 2005
Date of Patent:
January 22, 2013
Assignees:
Universita' Delgi Studi “Tor Vergate”, Institute Fisioterapici Ospitalieri
Inventors:
Luigi Giusto Spagnoli, Sabina Pucci, Elena Bonanno, Flavia Pichiorri, Gennaro Citro